Patented Medicine Prices Review Board
We are in the process of moving our services and information to Canada.ca.
Our current Patented Medicine Prices Review Board website will remain available until the move to Canada.ca is complete.
Draft Guidelines Consultation is now closed
We consulted with stakeholders and interested members of the public on the new Draft Guidelines following the amendments of the Patented Medicines Regulations.
Meds Entry Watch 2018
This is the fourth edition of the PMPRB’s Meds Entry Watch report, which explores the market entry of new medicines in Canada and other countries.
What we are doing
Report a problem or mistake on this page
- Date modified: